<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD986B3C-FB55-4C83-90D9-D28CA8B72E5E"><gtr:id>AD986B3C-FB55-4C83-90D9-D28CA8B72E5E</gtr:id><gtr:name>Exilica Ltd</gtr:name><gtr:address><gtr:line1>The Technocentre
Puma way</gtr:line1><gtr:city>Coventry</gtr:city><gtr:postCode>CV1 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD986B3C-FB55-4C83-90D9-D28CA8B72E5E"><gtr:id>AD986B3C-FB55-4C83-90D9-D28CA8B72E5E</gtr:id><gtr:name>Exilica Ltd</gtr:name><gtr:address><gtr:line1>The Technocentre
Puma way</gtr:line1><gtr:city>Coventry</gtr:city><gtr:postCode>CV1 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3"><gtr:id>5EDA5EBD-A5D5-4551-ABDF-22BBC5993EE3</gtr:id><gtr:name>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A4252EE9-98DF-4F4C-8536-F9A3F89C5417"><gtr:id>A4252EE9-98DF-4F4C-8536-F9A3F89C5417</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>May</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601171"><gtr:id>27BF5FC2-F07E-4388-8C34-DAF9078E49F1</gtr:id><gtr:title>Identifying the mechanism of intracellular parasitism by Cryptococcus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601171</gtr:grantReference><gtr:abstractText>Cryptococcus is a free-living fungus that is able to cause a fatal infection in humans and other animals. Our current understanding of this disease suggests that fungal spores are inhaled into the lung and then ?hide? from the immune system, sometimes for several years, by living inside a particular type of host cell called a macrophage. Although this cell would kill most other pathogens, Cryptococcus has a remarkable ability to survive and indeed grow inside macrophages. In addition, we have recently discovered that the fungus is also able to ?escape? from inside of this host cell by a novel process called ?reverse phagocytosis?. This process is likely to be advantageous to the pathogen since it does not damage the host cell and is therefore unlikely to trigger a strong inflammatory response. 

In order to develop better treatments for this lethal disease, we need to understand how the fungus can manipulate the host cell in this way. Our application is therefore directed at learning more about the molecular process that underlies this behaviour. In particular, we hope to answer two specific questions:
1) can we identify new ways in which human macrophages can be induced to destroy intracellular cryptococci and thereby eradicate latent infections?
2) how great is the risk that particular strains of Cryptococcus will become more dangerous to patients by evolving an improved ability to manipulate host cells in this way?</gtr:abstractText><gtr:technicalSummary>Cryptococcosis is a life-threatening disease of the central nervous system caused by the fungus Cryptococcus neoformans. The disease is uniformly fatal without rapid clinical intervention and even with the best available anti-fungal treatment, patient mortality exceeds 10%, rising to 88% in areas of the world with poor healthcare infrastructure. Cryptococcosis is primarily a disease of immunocompromised hosts (especially AIDS patients), although some strains of the closely related species C. gattii have the capacity to infect and kill immunocompetent individuals.
 
Pathogenic cryptococci show a remarkable ability to survive and proliferate within host macrophages following phagocytosis and are also capable of exiting the host cell via a unique, non-lytic, mechanism. Together these behaviours are thought to underlie the capacity of the pathogen to remain latent within the human host for long periods and, similarly, to cause relapsing episodes of cryptococcosis in patients after initially successful antifungal treatment. Importantly, this aspect of the disease means that infected patients are currently advised to remain on lifelong antifungal medication, despite the considerable cost and toxicity issues associated with this treatment regime. Thus an improved understanding of the cryptococcal-macrophage interaction may lead to significant improvements in our management of latent cryptococcosis.

We therefore propose to build on recent preliminary work from our group and use high-throughput timelapse microscopy to investigate how the normal cell biology of a macrophage is manipulated by Cryptococcus. In particular, we hypothesise that two factors may influence the outcome of this interaction. Firstly, it is known that changes in host inflammatory signalling (for example, in the levels of T-cell derived cytokines) alter cryptococcal disease progression. We therefore propose to investigate whether this may, in part, result from an effect on infected macrophages. Secondly, there is a wealth of data showing that variability in Cryptococcus genotype strongly influences virulence in mammals. We therefore propose to investigate what effect pathogen genotype and phenotype have on intracellular parasitism by this pathogen and thus better understand what risk novel cryptococcal strains may present to human health.

In summary, this proposal is intended to address an important aspect of the host-pathogen interaction in this fatal disease. By understanding the molecular basis of this interaction, we hope to identify possible targets for therapeutic intervention in the future and thereby improve long-term prognosis for infected patients.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>375119</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Exilica Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>INDEX commercialisation contract</gtr:description><gtr:id>542EF5D0-5B69-4008-ACA1-8D5A785C362D</gtr:id><gtr:impact>The industrial partner became aware of our MRC-funded work on live cell imaging and approached us for commercial imaging work, which we have now completed.</gtr:impact><gtr:outcomeId>777AD4B2261-1</gtr:outcomeId><gtr:piContribution>High-resolution imaging of nanoparticle uptake.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Netherlands Academy of Arts and Sciences (KNAW)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Fungal Biodiversity Center (CBS)</gtr:department><gtr:description>Collaboration with Boekhout Lab, Netherlands</gtr:description><gtr:id>D6AEB815-4F19-4341-A36D-1778E49752F9</gtr:id><gtr:impact>Joint publication (PMID: 19651610) Named collaboration on recently funded grant (Wellcome Trust)</gtr:impact><gtr:outcomeId>BDB0DCB1B00-1</gtr:outcomeId><gtr:partnerContribution>Joint research and publication (PMID: 19651610)</gtr:partnerContribution><gtr:piContribution>Research exchange (Hansong Ma from my group visited and worked with Ferry Hagen in the Boekhout lab), resulting in joint data and a joint publication (PMID: 19651610)</gtr:piContribution><gtr:sector>Learned Society</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Tihana Bicanic</gtr:description><gtr:id>AD4FCCEC-1BD0-4394-A7EB-F61F4FBD2783</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:outcomeId>HCodTrZ4NPi-1</gtr:outcomeId><gtr:partnerContribution>Provision of clinical samples for analysis</gtr:partnerContribution><gtr:piContribution>Conducting in vitro cell testing of clinical fungal isolates</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Heitman laboratory, Duke, USA</gtr:description><gtr:id>CC04BFEE-847A-452D-866A-E13FB8A486A1</gtr:id><gtr:impact>Resulted in preliminary data for a grant funded by the Wellcome Trust. Joint publication (PMID: 20421942)</gtr:impact><gtr:outcomeId>FBCC6EB0ABC-1</gtr:outcomeId><gtr:partnerContribution>Ongoing research collaboration</gtr:partnerContribution><gtr:piContribution>Research visit by Hansong Ma (PhD student) and subsequently myself to Duke University. Resulted in preliminary data for a grant, recently funded by the Wellcome Trust</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science museum day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EE120CF4-3D09-42D4-8FF1-2F3667F3DB4B</gtr:id><gtr:impact>Ran a 'meet the scientists' day at the Birmingham ThinkTank (science museum) for &amp;gt;200 school-age pupils and their families.

Considerable interest from pupils and parents in having repeat workshops, ideally via their schools.</gtr:impact><gtr:outcomeId>riVU9fPaou2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Off-topic' seminar, Culham Centre for Fusion Energy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>59E43818-D958-407F-BF2A-11C61CA17E21</gtr:id><gtr:impact>Seminar to physicists, engineers and mathematicians working at the Culham research facility on fusion energy.

Very positive feedback from the audience.</gtr:impact><gtr:outcomeId>h2CQetMEmMk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit - Bromsgrove</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D58E72F5-D2D0-47D5-ACD1-EB1BCF40AC2E</gtr:id><gtr:impact>Ran an interactive session on infectious diseases with 6th formers

Have accepted invitations to return to the same school next year, and an additional invitation to a different school to run the same programme</gtr:impact><gtr:outcomeId>8B2E00AFF34</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit, Sutton Coldfield</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>007C6872-848D-4704-8328-49B66E703A0E</gtr:id><gtr:impact>&amp;gt; 100 pupils attended a &amp;quot;general interest&amp;quot; talk on infectious disease, including our own work.

School requested ongoing outreach connection with our group.</gtr:impact><gtr:outcomeId>XF2U3SLwrhe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>318000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Investigating the molecular basis of cryptococcal hypervirulence underlying the Vancouver Outbreak)</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7A6F4241-25BE-43A2-B83A-ABC64FEF6CE2</gtr:id><gtr:outcomeId>3A0A038AE850</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Fellowship</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>3838115D-3E21-4303-AB68-BB4C6909514C</gtr:id><gtr:outcomeId>he9eHrddkpf0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Developed assay for quantifying intracellular proliferation of fungal pathogens. Now being widely adopted by other groups internationally.</gtr:description><gtr:id>68492EAA-6D30-4D4B-AA6F-6C95A6631525</gtr:id><gtr:impact>Joint publication (PMID: 20421942); ongoing collaboration with Tihana Bicanic, St. Georges, London.</gtr:impact><gtr:outcomeId>pZFdUbDQCRc</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Intracellular proliferation assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/20421942</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9DD5BE4A-758A-42B7-81C4-7AEE2300DBCB</gtr:id><gtr:title>Cryptococcal interactions with the host immune system.</gtr:title><gtr:parentPublicationTitle>Eukaryotic cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-9786</gtr:issn><gtr:outcomeId>DtUg6PeWyEq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BCDBFF6-887D-4F3D-8D7F-2CE452501825</gtr:id><gtr:title>Mitochondria and the regulation of hypervirulence in the fatal fungal outbreak on Vancouver Island.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64e7820c2cac5febc19e6b9d4ccb3d0"><gtr:id>c64e7820c2cac5febc19e6b9d4ccb3d0</gtr:id><gtr:otherNames>Ma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>83ED321B_283ED321B_2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF5687CE-17CF-4824-9589-3A4D8191E239</gtr:id><gtr:title>Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bcb43cf20e9a525a55b6101778520c9"><gtr:id>7bcb43cf20e9a525a55b6101778520c9</gtr:id><gtr:otherNames>Beale MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5675e7518453e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>082AB4AA-26DF-45DB-B95A-90E89040839B</gtr:id><gtr:title>The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd8c9d9600f2ef429868b82ca5e1e50"><gtr:id>6dd8c9d9600f2ef429868b82ca5e1e50</gtr:id><gtr:otherNames>Johnston SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>HdsR2yWhyaq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7A71C66-0940-4EE6-8B4D-DC3A9AC7C0EE</gtr:id><gtr:title>Mechanisms of microbial escape from phagocyte killing.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1f5fc01da53864652718aa884941e3"><gtr:id>0b1f5fc01da53864652718aa884941e3</gtr:id><gtr:otherNames>Smith LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_12905_25_23514140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3C9585-069D-492D-854F-501F88B4A4A8</gtr:id><gtr:title>SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02c0fcf2bb835c19a9277c0f69198123"><gtr:id>02c0fcf2bb835c19a9277c0f69198123</gtr:id><gtr:otherNames>Chayakulkeeree M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>pm_12905_25_21453402</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D313A05-5826-4C80-97EB-FD71E826A341</gtr:id><gtr:title>Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>A0C4979B_7A0C4979B_7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>567FD808-FAFC-4C2B-A91B-E4D3A05CF4DB</gtr:id><gtr:title>A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0421149ab66f23f580c8c8d51afc6395"><gtr:id>0421149ab66f23f580c8c8d51afc6395</gtr:id><gtr:otherNames>Byrnes EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_12905_25_21909264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>079FCD8A-42EF-405A-9355-117D1815A1CE</gtr:id><gtr:title>Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0421149ab66f23f580c8c8d51afc6395"><gtr:id>0421149ab66f23f580c8c8d51afc6395</gtr:id><gtr:otherNames>Byrnes EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>550041A18B8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE6AF89D-D127-4902-B24F-8F5F861EE223</gtr:id><gtr:title>'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>554cc555ccf7d5.89934153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8726167-AF0B-4F16-AB6B-BE7D1B5398EF</gtr:id><gtr:title>Transmission of Hypervirulence traits via sexual reproduction within and between lineages of the human fungal pathogen cryptococcus gattii.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_12905_25_24039607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23ECD43B-3B9F-4CB8-B343-0CA68AB07009</gtr:id><gtr:title>Actin polymerization driven by WASH causes V-ATPase retrieval and vesicle neutralization before exocytosis.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/977f8cbcf520eb528d32f24f04124ba1"><gtr:id>977f8cbcf520eb528d32f24f04124ba1</gtr:id><gtr:otherNames>Carnell M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_12905_25_21606208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20A03B1E-BA74-40D8-88A5-8B4154F74019</gtr:id><gtr:title>Cryptococcus neoformans Thermotolerance to Avian Body Temperature Is Sufficient For Extracellular Growth But Not Intracellular Survival In Macrophages.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dd8c9d9600f2ef429868b82ca5e1e50"><gtr:id>6dd8c9d9600f2ef429868b82ca5e1e50</gtr:id><gtr:otherNames>Johnston SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d584a4eaaf31.55634536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C0A403E-CD4C-44BE-B818-9B32BA5627EC</gtr:id><gtr:title>Virulence in Cryptococcus species.</gtr:title><gtr:parentPublicationTitle>Advances in applied microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64e7820c2cac5febc19e6b9d4ccb3d0"><gtr:id>c64e7820c2cac5febc19e6b9d4ccb3d0</gtr:id><gtr:otherNames>Ma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0065-2164</gtr:issn><gtr:outcomeId>56F475CA928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>556EABC1-C972-4126-B264-F9CDBC9570BE</gtr:id><gtr:title>A two-gene balance regulates Salmonella typhimurium tolerance in the nematode Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fb3d0fa090f6341278b45999edad8be"><gtr:id>2fb3d0fa090f6341278b45999edad8be</gtr:id><gtr:otherNames>Marsh EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12905_25_21399680</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02A3A9BC-12C8-41B0-9908-AFCBB5C5A45C</gtr:id><gtr:title>The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c64e7820c2cac5febc19e6b9d4ccb3d0"><gtr:id>c64e7820c2cac5febc19e6b9d4ccb3d0</gtr:id><gtr:otherNames>Ma H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>FAD3C1DC373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52D249AC-A505-4AE2-9DD3-C86A15D8F3A5</gtr:id><gtr:title>Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c785f6eb306ac4299dab556c4c0a6633"><gtr:id>c785f6eb306ac4299dab556c4c0a6633</gtr:id><gtr:otherNames>Voelz K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>0663B34BB5F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601171</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>